US Stock MarketDetailed Quotes

GANX Gain Therapeutics

Watchlist

1.820
+0.100+5.81%

Close Oct 4 16:00 ET

1.820
0.0000.00%

Post 20:02 ET

46.47MMarket Cap-1389P/E (TTM)

Gain Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-14.64%-5.76M

14.96%-3.59M

-28.41%-18.87M

-44.97%-5.66M

-20.60%-3.97M

0.59%-5.02M

-72.32%-4.22M

-18.81%-14.69M

5.83%-3.9M

-50.03%-3.29M

Net income from continuing operations

-5.92%-8.14M

21.86%-4.01M

-26.59%-22.27M

-1.06%-4.72M

-3.51%-4.72M

-51.18%-7.69M

-56.98%-5.14M

-26.64%-17.59M

-45.17%-4.67M

2.26%-4.56M

Depreciation and amortization

1.75%20.59K

6.68%20.53K

30.25%83.58K

30.25%23.59K

15.04%20.51K

1.09%20.24K

134.40%19.24K

314.41%64.17K

212.89%18.11K

331.15%17.83K

Other non cash items

-462.31%-166.13K

-63.74%-200.15K

-85.24%-383.19K

3.74%-135.7K

-377.36%-171.11K

--45.85K

---122.24K

-506.01%-206.86K

-1,892.18%-140.97K

-77.12%-35.85K

Change In working capital

-23.37%1.05M

-8.89%416.81K

-70.81%442.23K

-512.96%-1.38M

-100.56%-5.18K

624.31%1.37M

-10.39%457.47K

559.35%1.51M

124.14%334.02K

-45.83%931.5K

-Change in receivables

----

-3,682.15%-130.07K

----

105.73%3.63K

----

-Change in prepaid assets

-202.43%-403.3K

45.70%-298.47K

249.17%174.39K

-47.03%142.32K

-61.06%187.97K

13.36%393.74K

54.79%-549.64K

76.64%-116.91K

148.60%268.66K

-20.04%482.72K

-Change in payables and accrued expense

318.79%1.48M

-33.47%703.59K

-160.29%-643.16K

-109.23%-976.79K

-115.34%-46.1K

-32.87%-677.85K

-39.33%1.06M

304.59%1.07M

73.71%-466.85K

-74.17%300.59K

-Change in other current assets

----

143.07%152.35K

-Change in other current liabilities

----

-107.11%-50.53K

----

6.85%711.07K

----

-Change in other working capital

-101.84%-30.43K

123.14%11.68K

829.45%1.09M

-1,131.70%-371.34K

-3,266.10%-140K

1,781.46%1.65M

-196.73%-50.47K

-266.22%-149.65K

30.07%-30.15K

81.59%-4.16K

Cash from discontinued investing activities

Operating cash flow

-14.64%-5.76M

14.96%-3.59M

-28.41%-18.87M

-44.97%-5.66M

-20.60%-3.97M

0.59%-5.02M

-72.32%-4.22M

-18.81%-14.69M

5.83%-3.9M

-50.03%-3.29M

Investing cash flow

Cash flow from continuing investing activities

-34.25%2M

43.27%3.02M

169.19%10.22M

2,247.65%3.14M

17,002.33%1.93M

120.45%3.05M

27,026.26%2.11M

-15,582.52%-14.77M

1,305.89%133.83K

64.48%-11.41K

Net PPE purchase and sale

-491.30%-21.55K

--0

87.09%-15.36K

99.80%-19

98.86%-650

91.82%-3.64K

-41.15%-11.05K

-26.26%-118.95K

15.32%-9.4K

-78.00%-57.18K

Net investment purchase and sale

-33.62%2.02M

42.53%3.02M

169.86%10.24M

2,093.62%3.14M

4,115.55%1.93M

120.54%3.05M

--2.12M

---14.66M

--143.23K

--45.77K

Cash from discontinued investing activities

Investing cash flow

-34.25%2M

43.27%3.02M

169.19%10.22M

2,247.65%3.14M

17,002.33%1.93M

120.45%3.05M

27,026.26%2.11M

-15,582.52%-14.77M

1,305.89%133.83K

64.48%-11.41K

Financing cash flow

Cash flow from continuing financing activities

356.75%10.04M

-119.47%-145.8K

16,147.61%12.64M

44,398.94%9.56M

753.38%134.47K

161,115.26%2.2M

2,072.16%748.91K

-100.19%-78.77K

-121.69%-21.58K

-20.58K

Net issuance payments of debt

0.61%-22.11K

-5.83%-22.87K

-13.07%-89.07K

-4.62%-22.58K

-9.96%-22.63K

-1,732.13%-22.25K

43.09%-21.61K

-258.86%-78.77K

1.68%-21.58K

---20.58K

Net common stock issuance

352.55%10.04M

--0

--12.73M

--9.58M

--157.1K

--2.22M

--770.52K

--0

Proceeds from stock option exercised by employees

--13.58K

--157.94K

----

--0

----

Net other financing activities

--0

---280.87K

----

Cash from discontinued financing activities

Financing cash flow

356.75%10.04M

-119.47%-145.8K

16,147.61%12.64M

44,398.94%9.56M

753.38%134.47K

161,115.26%2.2M

2,072.16%748.91K

-100.19%-78.77K

-121.69%-21.58K

---20.58K

Net cash flow

Beginning cash position

77.31%10.67M

61.10%11.83M

-80.11%7.34M

-60.55%4.3M

-55.69%6.35M

-82.49%6.02M

-80.11%7.34M

391.88%36.91M

-73.40%10.91M

-66.82%14.34M

Current changes in cash

2,741.25%6.28M

47.59%-713.64K

113.53%4M

285.69%7.04M

42.68%-1.9M

101.11%221.11K

45.39%-1.36M

-200.81%-29.55M

8.99%-3.79M

-49.30%-3.32M

Effect of exchange rate changes

-88.21%13.12K

-1,251.69%-442.5K

2,152.38%488.4K

113.78%483.25K

-36.43%-144.58K

217.72%111.31K

177.91%38.42K

-123.61%-23.8K

250.42%226.05K

-407.61%-105.97K

End cash Position

167.14%16.97M

77.31%10.67M

61.10%11.83M

-60.55%4.3M

-55.69%6.35M

-82.49%6.02M

-80.11%7.34M

-73.40%10.91M

Free cash flow

-14.98%-5.78M

15.18%-3.59M

-27.48%-18.88M

-44.62%-5.66M

-18.56%-3.97M

1.39%-5.03M

-72.22%-4.23M

-18.87%-14.81M

5.86%-3.91M

-50.43%-3.35M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-14.64%-5.76M	14.96%-3.59M	-28.41%-18.87M	-44.97%-5.66M	-20.60%-3.97M	0.59%-5.02M	-72.32%-4.22M	-18.81%-14.69M	5.83%-3.9M	-50.03%-3.29M
Net income from continuing operations	-5.92%-8.14M	21.86%-4.01M	-26.59%-22.27M	-1.06%-4.72M	-3.51%-4.72M	-51.18%-7.69M	-56.98%-5.14M	-26.64%-17.59M	-45.17%-4.67M	2.26%-4.56M
Depreciation and amortization	1.75%20.59K	6.68%20.53K	30.25%83.58K	30.25%23.59K	15.04%20.51K	1.09%20.24K	134.40%19.24K	314.41%64.17K	212.89%18.11K	331.15%17.83K
Other non cash items	-462.31%-166.13K	-63.74%-200.15K	-85.24%-383.19K	3.74%-135.7K	-377.36%-171.11K	--45.85K	---122.24K	-506.01%-206.86K	-1,892.18%-140.97K	-77.12%-35.85K
Change In working capital	-23.37%1.05M	-8.89%416.81K	-70.81%442.23K	-512.96%-1.38M	-100.56%-5.18K	624.31%1.37M	-10.39%457.47K	559.35%1.51M	124.14%334.02K	-45.83%931.5K
-Change in receivables	----	----	-3,682.15%-130.07K	----	----	----	----	105.73%3.63K	----	----
-Change in prepaid assets	-202.43%-403.3K	45.70%-298.47K	249.17%174.39K	-47.03%142.32K	-61.06%187.97K	13.36%393.74K	54.79%-549.64K	76.64%-116.91K	148.60%268.66K	-20.04%482.72K
-Change in payables and accrued expense	318.79%1.48M	-33.47%703.59K	-160.29%-643.16K	-109.23%-976.79K	-115.34%-46.1K	-32.87%-677.85K	-39.33%1.06M	304.59%1.07M	73.71%-466.85K	-74.17%300.59K
-Change in other current assets	----	----	----	----	----	----	----	----	----	143.07%152.35K
-Change in other current liabilities	----	----	-107.11%-50.53K	----	----	----	----	6.85%711.07K	----	----
-Change in other working capital	-101.84%-30.43K	123.14%11.68K	829.45%1.09M	-1,131.70%-371.34K	-3,266.10%-140K	1,781.46%1.65M	-196.73%-50.47K	-266.22%-149.65K	30.07%-30.15K	81.59%-4.16K
Cash from discontinued investing activities
Operating cash flow	-14.64%-5.76M	14.96%-3.59M	-28.41%-18.87M	-44.97%-5.66M	-20.60%-3.97M	0.59%-5.02M	-72.32%-4.22M	-18.81%-14.69M	5.83%-3.9M	-50.03%-3.29M
Investing cash flow
Cash flow from continuing investing activities	-34.25%2M	43.27%3.02M	169.19%10.22M	2,247.65%3.14M	17,002.33%1.93M	120.45%3.05M	27,026.26%2.11M	-15,582.52%-14.77M	1,305.89%133.83K	64.48%-11.41K
Net PPE purchase and sale	-491.30%-21.55K	--0	87.09%-15.36K	99.80%-19	98.86%-650	91.82%-3.64K	-41.15%-11.05K	-26.26%-118.95K	15.32%-9.4K	-78.00%-57.18K
Net investment purchase and sale	-33.62%2.02M	42.53%3.02M	169.86%10.24M	2,093.62%3.14M	4,115.55%1.93M	120.54%3.05M	--2.12M	---14.66M	--143.23K	--45.77K
Cash from discontinued investing activities
Investing cash flow	-34.25%2M	43.27%3.02M	169.19%10.22M	2,247.65%3.14M	17,002.33%1.93M	120.45%3.05M	27,026.26%2.11M	-15,582.52%-14.77M	1,305.89%133.83K	64.48%-11.41K
Financing cash flow
Cash flow from continuing financing activities	356.75%10.04M	-119.47%-145.8K	16,147.61%12.64M	44,398.94%9.56M	753.38%134.47K	161,115.26%2.2M	2,072.16%748.91K	-100.19%-78.77K	-121.69%-21.58K	-20.58K
Net issuance payments of debt	0.61%-22.11K	-5.83%-22.87K	-13.07%-89.07K	-4.62%-22.58K	-9.96%-22.63K	-1,732.13%-22.25K	43.09%-21.61K	-258.86%-78.77K	1.68%-21.58K	---20.58K
Net common stock issuance	352.55%10.04M	--0	--12.73M	--9.58M	--157.1K	--2.22M	--770.52K	--0	--0	--0
Proceeds from stock option exercised by employees	--13.58K	--157.94K	----	----	----	--0	--0	----	----	----
Net other financing activities	--0	---280.87K	----	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	356.75%10.04M	-119.47%-145.8K	16,147.61%12.64M	44,398.94%9.56M	753.38%134.47K	161,115.26%2.2M	2,072.16%748.91K	-100.19%-78.77K	-121.69%-21.58K	---20.58K
Net cash flow
Beginning cash position	77.31%10.67M	61.10%11.83M	-80.11%7.34M	-60.55%4.3M	-55.69%6.35M	-82.49%6.02M	-80.11%7.34M	391.88%36.91M	-73.40%10.91M	-66.82%14.34M
Current changes in cash	2,741.25%6.28M	47.59%-713.64K	113.53%4M	285.69%7.04M	42.68%-1.9M	101.11%221.11K	45.39%-1.36M	-200.81%-29.55M	8.99%-3.79M	-49.30%-3.32M
Effect of exchange rate changes	-88.21%13.12K	-1,251.69%-442.5K	2,152.38%488.4K	113.78%483.25K	-36.43%-144.58K	217.72%111.31K	177.91%38.42K	-123.61%-23.8K	250.42%226.05K	-407.61%-105.97K
End cash Position	167.14%16.97M	77.31%10.67M	61.10%11.83M	61.10%11.83M	-60.55%4.3M	-55.69%6.35M	-82.49%6.02M	-80.11%7.34M	-80.11%7.34M	-73.40%10.91M
Free cash flow	-14.98%-5.78M	15.18%-3.59M	-27.48%-18.88M	-44.62%-5.66M	-18.56%-3.97M	1.39%-5.03M	-72.22%-4.23M	-18.87%-14.81M	5.86%-3.91M	-50.43%-3.35M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data